Expert Rev of Obstet Gynecol. 2010;5(6):673-686. Each year worldwide, over 380,000 women die from pregnancy and pregnancy-related causes. If contraception were made available to unprotected women, ...

The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman’s risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three ...

In my adolescent family planning clinic, we often prescribe DMPA to adolescents who cannot remember to take their oral contraceptive pills and to those who want the convenience of less menstrual ...

SEATTLE – April 4, 2012 – The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that ...

To compare longitudinal changes in weight, body fat, and ratio of central to peripheral fat mass among first-time depot-medroxyprogesterone acetate (DMPA) users to women using no hormonal ...

Seattle, April 12, 2018--Evidence published today on a new contraceptive option is providing one possible answer to an age-old question in family planning: how to address barriers that make it ...

Since its introduction nearly 23 years ago, the popular injectable contraceptive depot medroxyprogesterone acetate (DMPA) has been associated with causing substantial weight gain in some adolescent ...

DMPA SC does not protect against HIV infection (AIDS) or other sexually transmitted diseases. Injection site reactions such as injection site pain, injection site tenderness, injection site nodules, ...

The FINANCIAL — Pfizer Inc. announced on September 24 that the company’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for ...